We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

131 hedge funds and large institutions have $733M invested in AnaptysBio in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 52 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.42% more ownership

Funds ownership: 100.88% → 107.31% (+6.4%)

4% less funds holding

Funds holding: 136 → 131 (-5)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

24% less capital invested

Capital invested by funds: $963M → $733M (-$230M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

37% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 52

Holders
131
Holders Change
-5
Holders Change %
-3.68%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
33
Reduced
52
Closed
22
Calls
$362K
Puts
–
Net Calls
+$362K
Net Calls Change
-$1.15M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$32.1M
2
DTC
Deep Track Capital
Connecticut
+$16.9M
3
LGM
Logos Global Management
California
+$9.08M
4
WP
Woodline Partners
California
+$6.78M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.75M

Top Sellers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
-$31.3M
2
N
Natixis
France
-$4.32M
3
Walleye Capital
Walleye Capital
New York
-$2.7M
4
Goldman Sachs
Goldman Sachs
New York
-$2.65M
5
EP
Eversept Partners
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$4.2M -$1.31M -43,121 -20%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$3.78M -$1.13M -37,265 -20%
Charles Schwab
28
Charles Schwab
California
$3.52M +$176K +5,819 +4%
EP
29
Eversept Partners
New York
$2.82M -$2.07M -68,447 -37%
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$2.76M +$669K +22,090 +25%
Los Angeles Capital Management
31
Los Angeles Capital Management
California
$2.61M -$493K -16,285 -13%
Morgan Stanley
32
Morgan Stanley
New York
$2.6M +$976K +32,264 +44%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.1M -$26.2K -865 -1%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.94M -$292K -9,642 -11%
ECM
35
ExodusPoint Capital Management
New York
$1.92M +$2.34M +77,446 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$1.92M -$1.46M -48,100 -38%
Massachusetts Financial Services
37
Massachusetts Financial Services
Massachusetts
$1.69M -$394K -13,003 -16%
Fisher Asset Management
38
Fisher Asset Management
Washington
$1.68M +$256K +8,468 +14%
JAM
39
Jupiter Asset Management
United Kingdom
$1.5M +$45.2K +1,494 +3%
TCM
40
TCG Crossover Management
California
$1.45M +$1.77M +58,515 New
Renaissance Technologies
41
Renaissance Technologies
New York
$1.44M +$717K +23,700 +68%
Ameriprise
42
Ameriprise
Minnesota
$1.37M +$390K +12,902 +30%
PPA
43
Parametric Portfolio Associates
Washington
$1.33M -$24K -794 -1%
CAM
44
Cormorant Asset Management
Massachusetts
$1.24M -$1.51M -50,000 -50%
UBS Group
45
UBS Group
Switzerland
$1.19M +$647K +21,375 +80%
Allspring Global Investments
46
Allspring Global Investments
North Carolina
$1.17M +$604K +19,956 +73%
Rafferty Asset Management
47
Rafferty Asset Management
New York
$1.15M +$97.8K +3,230 +7%
Ensign Peak Advisors
48
Ensign Peak Advisors
Utah
$1.12M +$15.4K +510 +1%
Two Sigma Investments
49
Two Sigma Investments
New York
$1.07M -$1.31M -43,321 -50%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.05M +$93.8K +3,100 +8%
1
2
3 4 5

ANAB Hedge Fund Activity: Q1 2022 in Review

131 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q1 2022, worth a combined $733M — down 24% from $963M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ANAB and 17 opened new positions — a net loss of 5 holders — while 52 trimmed existing stakes and 33 added.

The largest buyer was Point72 Asset Management, adding an estimated $32.1M. The largest seller was Frazier Management, exiting entirely with an estimated $31.3M sold.

  • 131 institutional investors held AnaptysBio (ANAB) as of Q1 2022, down from 136 in Q4 2021.
  • Funds reported $733M of AnaptysBio stock for Q1 2022, down 24% quarter-over-quarter.
  • 17 funds opened new AnaptysBio positions in Q1 2022 and 22 closed out, a net change of -5 holders.
  • The largest AnaptysBio buyer in Q1 2022 was Point72 Asset Management, an estimated $32.1M added.
  • The largest AnaptysBio seller in Q1 2022 was Frazier Management, an estimated $31.3M sold.

Based on aggregated 13F filings for Q1 2022.